$GALE @ 1.34 premarket, what are Analysts rep
Post# of 23071
(Total Views: 74)
Posted On: 02/02/2017 9:11:43 AM
$GALE @ 1.34 premarket,
what are Analysts report about: Galena Biopharma, Inc. (NASDAQ:GALE)
By Jill Kemp -
Feb 2, 2017
0
10
Galena Biopharma, Inc. (NASDAQ:GALE) will report its next earnings on Mar 8 – Mar 13 (Est.). The company reported the earnings of $-0.6/Share in the last quarter where the estimated EPS by analysts was $-0.9/share. The difference between the expected and actual EPS was $0.3/share, which represents an Earnings surprise of 33.3%.
Many analysts are providing their Estimated Earnings analysis for Galena Biopharma, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.77/share. These analysts have also projected a Low Estimate of $-1.03/share and a High Estimate of $-0.41/share.
Some buy side analysts are also providing their Analysis on Galena Biopharma, Inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 2 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
Finance 2
00:00
Share
Playlist
Link
Copy to clipboard: Ctrl+C / Cmd+C
Embed
Copy to clipboard: Ctrl+C / Cmd+C
When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for Galena Biopharma, Inc. might touch $11 high while the Average Price Target and Low price Target is $7.67 and $4 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Galena Biopharma, Inc. got Downgrade on 29-Jun-16 where investment firm Raymond James Downgrade the stock from Outperform to Mkt Perform.
Galena Biopharma, Inc. closed its last trading session at $1.65 with the loss of -22.42%. The Market Capitalization of the company stands at 13.9 Million. The Company has 52-week high of $4.75 and 52-week low of $0.16. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -31.59% where SMA50 and SMA200 are -44.75% and -90.04% respectively. The Company Touched its 52-Week High on Nov 21, 2016 and 52-Week Low on Nov 9, 2016.
The Relative Volume of the company is 1.31 and Average Volume (3 months) is 1.46 million. Galena Biopharma, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -51.1%. The Return on Equity (ROE) value stands at -214.9%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Galena Biopharma, Inc. currently shows a Weekly Performance of -30.43%, where Monthly Performance is -34.02%, Quarterly performance is -72.17%, 6 Months performance is -85.12% and yearly performance percentage is -89.68%. Year to Date performance value (YTD perf) value is -34.02%. The Stock currently has a Weekly Volatility of 9.29% and Monthly Volatility of 8.75%.
what are Analysts report about: Galena Biopharma, Inc. (NASDAQ:GALE)
By Jill Kemp -
Feb 2, 2017
0
10
Galena Biopharma, Inc. (NASDAQ:GALE) will report its next earnings on Mar 8 – Mar 13 (Est.). The company reported the earnings of $-0.6/Share in the last quarter where the estimated EPS by analysts was $-0.9/share. The difference between the expected and actual EPS was $0.3/share, which represents an Earnings surprise of 33.3%.
Many analysts are providing their Estimated Earnings analysis for Galena Biopharma, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.77/share. These analysts have also projected a Low Estimate of $-1.03/share and a High Estimate of $-0.41/share.
Some buy side analysts are also providing their Analysis on Galena Biopharma, Inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 2 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
Finance 2
00:00
Share
Playlist
Link
Copy to clipboard: Ctrl+C / Cmd+C
Embed
Copy to clipboard: Ctrl+C / Cmd+C
When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for Galena Biopharma, Inc. might touch $11 high while the Average Price Target and Low price Target is $7.67 and $4 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Galena Biopharma, Inc. got Downgrade on 29-Jun-16 where investment firm Raymond James Downgrade the stock from Outperform to Mkt Perform.
Galena Biopharma, Inc. closed its last trading session at $1.65 with the loss of -22.42%. The Market Capitalization of the company stands at 13.9 Million. The Company has 52-week high of $4.75 and 52-week low of $0.16. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -31.59% where SMA50 and SMA200 are -44.75% and -90.04% respectively. The Company Touched its 52-Week High on Nov 21, 2016 and 52-Week Low on Nov 9, 2016.
The Relative Volume of the company is 1.31 and Average Volume (3 months) is 1.46 million. Galena Biopharma, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -51.1%. The Return on Equity (ROE) value stands at -214.9%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Galena Biopharma, Inc. currently shows a Weekly Performance of -30.43%, where Monthly Performance is -34.02%, Quarterly performance is -72.17%, 6 Months performance is -85.12% and yearly performance percentage is -89.68%. Year to Date performance value (YTD perf) value is -34.02%. The Stock currently has a Weekly Volatility of 9.29% and Monthly Volatility of 8.75%.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'